osimertinib mesylate
Osimertinib Mesylate is used to treat locally advanced or metastatic non-small-cell lung cancer. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.Reference standards of Osimertinib Mesylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Osimertinib Mesylate - API Standards
[catalogue_number] => PA 15 60000
[category_ids] => ,78,70,82,79,80,88,
[chemical_name] =>
[weight] => 595.71
[form] => C29H37N7O5S
[cas] => 1421373-66-1
[pslug] => 1421373-66-1-osimertinib-mesylate-api-pa1560000
[latest_product] => 0
[linkproducts] => 1
[offers_id] => 1
[offers_name] => Spring Season Offer
[offers_status] => 1
[offers_start_date] => 2024-03-27
[offers_end_date] => 2024-03-31
[pageview] => 2
[offers_slug] => spring-season-offer
[offers_product_id] => 3515
[offers_product_code] => PA 15 60000
[offers_master_id] => 1
[offer_percentage] => 20% OFF
[offers_product_main_cat] => Pharmaceutical Reference Standards
)
Osimertinib Mesylate - API Standards
Catalogue No.:PA 15 60000
Molecular Formula : C29H37N7O5S
Molecular Weight : 595.71